Büşra Gürel, Eda Çapkın, Ayhan Parlar, Aylin Özkan, Meltem Çorbacıoğlu, Duygu Emine Dağlikoca, & Meral Yüce. (2022). Optimized Methods for Analytical and Functional Comparison of Biosimilar mAb Drugs: A Case Study for Avastin, Mvasi, and Zirabev. MDPI AG.
Chicago Style (17th ed.) CitationBüşra Gürel, Eda Çapkın, Ayhan Parlar, Aylin Özkan, Meltem Çorbacıoğlu, Duygu Emine Dağlikoca, and Meral Yüce. Optimized Methods for Analytical and Functional Comparison of Biosimilar MAb Drugs: A Case Study for Avastin, Mvasi, and Zirabev. MDPI AG, 2022.
MLA (9th ed.) CitationBüşra Gürel, et al. Optimized Methods for Analytical and Functional Comparison of Biosimilar MAb Drugs: A Case Study for Avastin, Mvasi, and Zirabev. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.